RxDoctor Payments Data

Evan Breth, DPM

Foot Surgery · Brooklyn, NYNPI 1023097052

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Osteomed LLC accounts for 87.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $12,161 and has fallen 98.7% since, to $164 in 2025. Among foot surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,927in general payments, 2019–2025

Across 74 payments — averaging $228.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Osteomed LLC$15K
  • Acumed LLC$847
  • Stryker$713
  • Smith+Nephew$280
  • Biocomposites Inc$164
  • GSK$25
  • plus $22 from 1 others

What the payments were for

  • Consulting fees$8,17548%
  • Speaking & faculty fees$4,25025%
  • Travel & lodging$1,63610%
  • Food & beverage$2,32414%
  • Education$5073%
  • Gifts$350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Osteomed LLC40$14,877
Acumed LLC16$847
Stryker(2 entities)7$713
Smith+Nephew8$280
Biocomposites Inc1$164
GSK1$25
Advanced Oxygen Therapy Inc.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,927 in reported general payments places this provider in the 95th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$120,274
Medicare patients
205
Services billed
2,230

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole64$1,681
Mometasone Furoate43$711
Mupirocin70$445
Cefadroxil44$347
Ciclopirox19$288
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$232

Paid to pharmacies, not to this prescriber.

Other foot surgery in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →